1. Antitumor activity of platinum analogs;Bradner,1980
2. Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum (IV) (CHIP);Creaven;Cancer Treat Rep,1983
3. A phase I study of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum (IV) (CHIP) administered by intravenous bolus daily for 5 days;Ginsberg,1983
4. Phase I clinical evaluation of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP-JM9);Yap,1983
5. Activity of JM 9 in advanced ovarian cancer: a phase I–II trial;Bramwell;Cancer Treat Rep,1985